295 results on '"Itoh, Hideki"'
Search Results
2. Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy
3. Novel CALM3 Variant Causing Calmodulinopathy With Variable Expressivity in a 4-Generation Family
4. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
5. Impact of Updated Diagnostic Criteria for Long QT Syndrome on Clinical Detection of Diseased Patients: Results From a Study of Patients Carrying Gene Mutations
6. Neonatal Wnt-dependent Lgr5 positive stem cells are essential for uterine gland development
7. Novel CACNA1C R511Q mutation, located in domain Ⅰ-Ⅱ linker, causes non-syndromic type-8 long QT syndrome
8. Carvedilol, a Non-Selective β-with α1-Blocker is Effective in Long QT Syndrome Type 2
9. The genetics underlying acquired long QT syndrome: impact for genetic screening
10. Microscopic heat pulses activate cardiac thin filaments
11. Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes
12. Differences in Pharmaceutical Intervention Triggers for the Optimization of Medication by Patient Age: A University Hospital Study
13. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls
14. A Novel SCN5A Gain-of-Function Mutation M1875T Associated With Familial Atrial Fibrillation
15. Hydroxyzine, a First Generation H1-Receptor Antagonist, Inhibits Human Ether-a-go-go–Related Gene (HERG) Current and Causes Syncope in a Patient With the HERG Mutation
16. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction
17. JCS/JHRS2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
18. Corrigendum to “A challenge for mutation specific risk stratification in long QT syndrome type 1” [J. Cardiol. 72(1) (2018) 56–65]
19. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome
20. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
21. Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations
22. High incidence of major bleeding with off-label use of edoxaban
23. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls
24. Numerical analysis of relative humidity distribution in polymer electrolyte fuel cell stack including cooling water
25. Effect of flow pattern of gas and cooling water on relative humidity distribution in polymer electrolyte fuel cell
26. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents
27. Genetic Background of Catecholaminergic Polymorphic Ventricular Tachycardia in Japan
28. Age-Dependent Clinical and Genetic Characteristics in Japanese Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
29. Systematic Evaluation of KCNQ1 Variant Using ACMG/AMP Guidelines and Risk Stratification in Long QT Syndrome Type 1
30. Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1
31. Single-cell temperature mapping with fluorescent thermometer nanosheets
32. Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy
33. Heart rate-dependent variability of cardiac events in type 2 congenital long-QT syndrome
34. Low HDL Cholesterol Is Associated With the Risk of Stroke in Elderly Diabetic Individuals: Changes in the risk for atherosclerotic diseases at various ages
35. Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients
36. A hERG mutation E1039X produced a synergistic lesion on IKs together with KCNQ1-R174C mutation in a LQTS family with three compound mutations
37. Optical visualisation of thermogenesis in stimulated singlecell brown adipocytes
38. Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1.
39. A challenge for mutation specific risk stratification in long QT syndrome type 1
40. Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation
41. Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome
42. A hERG mutation E1039X produced a synergistic lesion on IKs together with KCNQ1-R174C mutation in a LQTS family with three compound mutations
43. Usefulness of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in a Patient With Takayasu's Arteritis Associated With Antiphospholipid Syndrome
44. 顕微温度計測及び細胞機能における温度の効果
45. Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote
46. Optical visualisation of thermogenesis in stimulated single-cell brown adipocytes
47. Drug-induced Brugada-type Electrocardiogram: A Cause of Sudden Death in Patients with Schizophrenia?
48. Patient-specific human induced pluripotent stem cell model assessed with electrical pacing validates S107 as a potential therapeutic agent for catecholaminergic polymorphic ventricular tachycardia
49. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia
50. A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.